Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

17.60
Delayed Data
As of 3:59pm ET
 +0.45 / +2.62%
Today’s Change
7.02
Today|||52-Week Range
17.75
+45.45%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close17.15
Today’s open17.20
Day’s range17.00 - 17.65
Volume281,056
Average volume (3 months)398,380
Market cap$999.0M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...+0.40+2.95%
XLRNAcceleron Pharma Inc+0.58+2.17%
FPRXFive Prime Therapeut...+0.28+0.78%
CHRSCoherus BioSciences ...-0.05-0.23%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs